Hector Tamez Aguilar
Interventional Cardiology · Boston, MANPI 1609048909
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (35.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 25.4% of the total. Among interventional cardiology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 271 payments — averaging $454.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$31K
- Shockwave Medical, Inc$30K
- Abiomed$17K
- Medtronic$17K
- Boston Scientific$16K
- Biotronik Inc.$5K
- plus $6K from 8 others
Across 2 payments — averaging $28,077 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Shockwave Medical, Inc$56K
What the payments were for
- Consulting fees$40,52533%
- Speaking & faculty fees$43,90036%
- Travel & lodging$25,80221%
- Food & beverage$12,84710%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 53 | $31,262 |
| Shockwave Medical, Inc | 35 | $29,609 |
| Abiomed | 20 | $17,483 |
| Medtronic | 73 | $16,808 |
| Boston Scientific | 42 | $16,374 |
| Biotronik Inc. | 8 | $5,417 |
| Abbott | 6 | $3,457 |
| Heartflow, Inc. | 14 | $1,155 |
| Philips North America LLC | 7 | $647 |
| Teleflex LLC | 7 | $407 |
| Merit Medical Systems Inc | 1 | $200 |
| Cardiovascular Systems Inc. | 1 | $105 |
| Cathworks, Inc. | 3 | $86 |
| Corindus Inc. | 1 | $65 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$28,995
- Impella$17,261
- Artis icono floor$12,366
- RESOLUTE ONYX$7,550
- GENERAL BALLOONS$7,500
- Vitalyst$5,082
- COROFLOW$3,000
- AVVIGO Guidance System$1,663
- NAEOTOM Alpha$1,270
- FFRct$1,116
- ONYX FRONTIER$628
- GENERAL - THERAPIES$581
- Orsiro Mission$432
- Telescope$380
- Cios Spin$351
- SYMPLICITY G3$284
- Vascular Lithotripsy$271
- (6575) Coronary Undivided$235
- (6571) Eagle Eye$233
- GENERAL ATHERECTOMY$221
How this compares
$123,074 in reported general payments places this provider in the 90th percentile of 128 interventional cardiology providers in Massachusetts.
See all interventional cardiology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 27 | $32,358 |
| Repatha SureclickEvolocumab | 20 | $12,885 |
| Praluent PenAlirocumab | 13 | $6,931 |
| Metoprolol Succinate | 66 | $979 |
| Atorvastatin Calcium | 80 | $944 |
| Carvedilol | 33 | $587 |
| ClopidogrelClopidogrel Bisulfate | 27 | $547 |
| Losartan Potassium | 24 | $385 |
| Lisinopril | 17 | $167 |
| Pravastatin Sodium | 13 | $157 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 14 | $151 |
| Furosemide | 13 | $94 |
| Amlodipine Besylate | 18 | $58 |
| Hydrochlorothiazide | 15 | $32 |
| Rosuvastatin Calcium | 13 | $23 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Boston
- Eric SecemskyBoston$1.2M
- Darshan DoshiBoston$730K
- Charles GibsonBoston$661K
- Duane PintoBoston$491K
- Robert YehBoston$412K
- Suzanne BaronBoston$274K
- Farouc JafferBoston$213K
- Joseph GarasicBoston$152K
- Pinak ShahBoston$147K
- Douglas DrachmanBoston$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.